Related Experiment Videos

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Richard Coker1

  • 1Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK.

Abstract

No abstract available in PubMed .

Related Concept Videos